NEXTHERA CAPITAL LP

Q2 2019 13F Holdings

  • Location
    new york, NY
  • Num holdings

    23

  • Value ($000)

    $120,064

  • Date Filed
    08/14/2019
  • Form type
    13F-HR
  • CIK
    0001646343
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2019 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
I
ICPT

Intercept Pharmaceuticals Inc

COM
45845P108
$12.13M
10 %

152,441

I
INSM

Insmed Inc

COM PAR $.01
457669307
$12.05M
10 %

470,741

2
2393707D

Audentes Therapeutics Inc

COM
05070R104
$11.13M
9 %

294,013

N
NBIX

Neurocrine Biosciences Inc

COM
64125C109
$7.80M
7 %

92,380

S
SRPT

Sarepta Therapeutics Inc

COM
803607100
$7.65M
6 %

50,317

G
GBT

Global Blood Therapeutics Inc

COM
37890U108
$7.49M
6 %

142,305

I
IMMU

Immunomedics Inc

COM
452907108
$7.27M
6 %

524,140

C
CHRS

Coherus Biosciences Inc

COM
19249H103
$6.99M
6 %

316,316

A
ASND

Ascendis Pharma A/S

SPONSORED ADR
04351P101
$6.94M
6 %

60,266

P
PCRX

Pacira BioSciences Inc

COM
695127100
$6.48M
5 %

149,086

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 23